EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 205 filers reported holding EVOLENT HEALTH INC in Q3 2023. The put-call ratio across all filers is 3.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,769,797 | -6.8% | 358,788 | +3.8% | 0.29% | +2.5% |
| Q2 2023 | $10,478,195 | +2.5% | 345,815 | +9.8% | 0.28% | -3.4% |
| Q1 2023 | $10,217,726 | +107206.5% | 314,876 | -7.1% | 0.30% | -1.3% |
| Q4 2022 | $9,522 | -99.9% | 339,112 | +5.6% | 0.30% | -20.1% |
| Q3 2022 | $11,539,000 | -10.0% | 321,140 | -23.1% | 0.37% | -3.1% |
| Q2 2022 | $12,820,000 | -5.0% | 417,438 | -0.1% | 0.39% | +20.6% |
| Q1 2022 | $13,491,000 | -0.5% | 417,685 | -14.8% | 0.32% | +17.6% |
| Q4 2021 | $13,565,000 | -0.1% | 490,242 | +12.0% | 0.27% | -3.2% |
| Q3 2021 | $13,573,000 | -10.0% | 437,824 | -38.7% | 0.28% | +4.1% |
| Q2 2021 | $15,084,000 | -0.7% | 714,211 | -5.0% | 0.27% | -4.3% |
| Q1 2021 | $15,188,000 | +10.7% | 751,883 | -12.1% | 0.28% | +8.0% |
| Q4 2020 | $13,719,000 | +18.5% | 855,835 | -8.3% | 0.26% | -15.0% |
| Q3 2020 | $11,582,000 | +39.5% | 933,286 | -20.0% | 0.31% | +30.1% |
| Q2 2020 | $8,303,000 | +26.9% | 1,166,156 | -3.2% | 0.24% | +0.4% |
| Q1 2020 | $6,543,000 | -39.2% | 1,204,981 | +1.3% | 0.24% | -14.2% |
| Q4 2019 | $10,762,000 | -2.2% | 1,189,119 | -22.3% | 0.27% | -8.4% |
| Q3 2019 | $11,006,000 | +23.1% | 1,530,763 | +36.1% | 0.30% | +35.3% |
| Q2 2019 | $8,942,000 | -37.0% | 1,124,770 | -0.3% | 0.22% | -37.7% |
| Q1 2019 | $14,190,000 | -25.3% | 1,127,984 | +18.5% | 0.36% | -33.6% |
| Q4 2018 | $18,994,000 | -23.2% | 952,095 | +9.3% | 0.54% | -8.7% |
| Q3 2018 | $24,734,000 | +23.5% | 870,927 | -8.5% | 0.59% | +17.2% |
| Q2 2018 | $20,027,000 | +1.9% | 951,416 | -31.0% | 0.50% | +4.0% |
| Q1 2018 | $19,660,000 | -0.6% | 1,379,647 | -14.2% | 0.48% | +3.4% |
| Q4 2017 | $19,777,000 | -25.1% | 1,607,880 | +8.4% | 0.46% | -26.5% |
| Q3 2017 | $26,393,000 | +5.5% | 1,482,778 | +50.2% | 0.63% | +1.4% |
| Q2 2017 | $25,027,000 | +9.4% | 987,242 | -10.2% | 0.62% | +7.2% |
| Q1 2017 | $22,872,000 | +21.3% | 1,099,600 | -13.7% | 0.58% | +19.0% |
| Q4 2016 | $18,861,000 | -28.3% | 1,274,376 | +19.3% | 0.49% | -28.6% |
| Q3 2016 | $26,294,000 | – | 1,068,012 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FORMULA GROWTH LTD | 2,026,530 | $28,878,000 | 3.42% |
| Casdin Capital, LLC | 1,110,000 | $15,818,000 | 2.78% |
| Elk Creek Partners, LLC | 2,345,663 | $33,426,000 | 1.95% |
| Chicago Capital, LLC | 859,914 | $12,254,000 | 1.64% |
| Granahan Investment Management | 1,190,958 | $16,971,000 | 1.22% |
| White Pine Investment CO | 165,020 | $2,352,000 | 1.15% |
| RIVERBRIDGE PARTNERS LLC | 2,816,223 | $40,131,000 | 0.73% |
| SECTORAL ASSET MANAGEMENT INC | 423,482 | $6,035,000 | 0.66% |
| Trellus Management Company, LLC | 20,800 | $296,000 | 0.54% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 1,379,647 | $19,660,000 | 0.48% |